Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded oral solution containing triamcinolone acetonide, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing triamcinolone are listed in cream, ointment, injection, spray, paste and lotion forms. It is also a component of FDA-approved kits.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Triamcinolone acetonide is a synthetic corticosteroid that compounding pharmacies prepare by prescription in topical creams, ointments, gels, oral pastes and nasal preparations.
Triamcinolone acetonide is a glucocorticoid, a cortisol-like anti-inflammatory steroid. It calms inflammation by slowing the movement of white blood cells into irritated tissue, narrowing small blood vessels and reducing the signals that drive swelling, redness and itch. Several manufactured products exist. Topical creams, ointments, lotions and sprays are FDA-approved for the inflammation and itching of corticosteroid-responsive skin conditions, and a dental paste is approved for mouth sores. Kenalog-40 injectable suspension is FDA-approved for intramuscular use in allergic, dermatologic, rheumatic and other conditions and for injection into joints and soft tissue. A prescriber might order compounded triamcinolone when a patient needs a strength or vehicle that is not manufactured, a base without a preservative or fragrance the patient reacts to, or a combination with another topical ingredient. Compounded preparations are not FDA-approved and require a prescription.
Topical corticosteroids can be absorbed through the skin enough to suppress the body's own cortisol production (HPA axis suppression), raise blood sugar or cause Cushing's syndrome, especially with large areas, long use, occlusive dressings or in children, who absorb proportionally more and can have slowed growth. Local effects include burning, itching, dryness, acne, thinning skin, stretch marks, lightened skin and unwanted hair; call your prescriber for a severe rash or signs of infection. The injectable label says epidural and intrathecal injection is not recommended because serious neurologic events have occurred, and that anaphylaxis has happened by any route. Systemic corticosteroids interact with warfarin, diabetes medicines, ketoconazole, cyclosporine, NSAIDs, potassium-depleting diuretics and live vaccines. Do not use it if allergic to any component. The cream label lists pregnancy category C and the injectable label says to use it in pregnancy only if the benefit justifies the risk to the fetus; tell your prescriber if you are pregnant. LactMed considers short-term topical use unlikely to harm a breastfed infant but advises keeping treated skin off the baby. For side effects, talk to your prescriber or pharmacist.
Triamcinolone acetonide is a synthetic glucocorticoid whose anti-inflammatory activity follows glucocorticoid receptor binding, with inhibition of leukocyte migration, vasoconstriction, and antimitotic effects on keratinocytes and fibroblasts; the same review notes that dexamethasone, another corticosteroid, suppressed VEGF expression and fibroblast proliferation in keloid tissue (Morelli Coppola et al., 2018). The Kenalog-40 label describes an extended duration of several weeks after intramuscular injection, with adrenal suppression beginning within 24 to 48 hours and typically resolving in 30 to 40 days; intra-articular doses may be absorbed systemically. Topical absorption rises with potency, surface area, duration and occlusion. Labeled indications: Triamcinolone Acetonide Cream USP (and ointment, lotion, spray) for corticosteroid-responsive dermatoses; Kenalog-40 for intramuscular use across allergic, dermatologic, endocrine, rheumatic and other listed conditions, and intra-articular or soft tissue use in gouty arthritis, bursitis, tenosynovitis, epicondylitis and osteoarthritis. Intralesional triamcinolone is described in the keloid literature as the most commonly used intralesional corticosteroid for keloids and hypertrophic scars (Morelli Coppola et al., 2018), an off-label use. Dosing, potency selection and duration are per prescriber. Monitor for HPA axis suppression with urinary free cortisol or ACTH stimulation testing when exposure is extensive, intraocular pressure beyond six weeks of systemic therapy, glucose in diabetics and signs of infection. Cholestyramine may increase corticosteroid clearance. Triamcinolone is not a controlled substance.
Measure each dose with the oral syringe or dosing cup provided, using the milliliter markings. Do not use household spoons. Take it by mouth as your label directs, with or without food as instructed. Rinse the measuring device after use and keep the bottle capped.
Oral solutions are aqueous. Under USP <795>, a preserved solution usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Your label shows whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
